INTERNATIONAL PATENT: EPICS THERAPEUTICS FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A BCL2 INHIBITOR"

GENEVA, Jan. 26 -- EPICS THERAPEUTICS (rue Adrienne Bolland 476041 Gosselies) filed a patent application (PCT/EP2025/070621) for "COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A BCL2 INHIBITOR" on Jul 18, 2025. With publication no. WO/2026/017844, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SORLET, Catherine (c/o EPICS THERAPEUTICSrue Adrienne Bolland 476041 Gosselies), PARMENTIER, Nicolas (c/o EPICS THERAPEUTICSrue Adrienne Bolland 476041 Gosselies), OUKOLOFF, Killian (c/o EPICS THERAPEUTICSrue Adrienne Bol...